Objectives:We characterized pairwise and higher order patterns of non-nucleoside reverse transcriptase inhibi-tor (NNRTI)-selected mutations because multiple mutations are usually required for clinically significant resist-ance to second-generation NNRTIs. Patients and methods: We analysed viruses from 13039 individuals with sequences containing at least one of 52 published NNRTI-selected mutations, including 1133 viruses from individuals who received efavirenz but no other NNRTI and 1510 viruses from individuals who received nevirapine but no other NNRTI. Of the 17 reported etravirine resistance-associated mutations (RAMs), Y181C/I/V, L100I, K101P and M230L were considered major based on published in vitro susceptibility data
Objectives: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy w...
OBJECTIVES: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy ...
OBJECTIVES: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy ...
Objectives:We characterized pairwise and higher order patterns of non-nucleoside reverse transcripta...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are ...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
BACKGROUND: Etravirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI)...
ObjectivesThe introduction of two new non-nucleoside reverse transcriptase inhibitors (NNRTIs) in th...
OBJECTIVES: Etravirine (ETV) is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) with r...
Objectives: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy w...
OBJECTIVES: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy ...
OBJECTIVES: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy ...
Objectives:We characterized pairwise and higher order patterns of non-nucleoside reverse transcripta...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are ...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
Resistance to antivirals is a complex and dynamic phenomenon that involves more mutations than are c...
BACKGROUND: Etravirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI)...
ObjectivesThe introduction of two new non-nucleoside reverse transcriptase inhibitors (NNRTIs) in th...
OBJECTIVES: Etravirine (ETV) is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) with r...
Objectives: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy w...
OBJECTIVES: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy ...
OBJECTIVES: To evaluate whether etravirine (TMC125) might be effective in patients failing therapy ...